Literature DB >> 21762679

NR2B-containing NMDA receptors promote neural progenitor cell proliferation through CaMKIV/CREB pathway.

Mei Li1, Dong-Qing Zhang, Xiang-Zhen Wang, Tie-Jun Xu.   

Abstract

Accumulating evidence indicates the involvement of N-methyl-D-aspartate receptors (NMDARs) in regulating neural stem/progenitor cell (NSPC) proliferation. Functional properties of NMDARs can be markedly influenced by incorporating the regulatory subunit NR2B. Here, we aim to analyze the effect of NR2B-containing NMDARs on the proliferation of hippocampal NSPCs and to explore the mechanism responsible for this effect. NSPCs were shown to express NMDAR subunits NR1 and NR2B. The NR2B selective antagonist, Ro 25-6981, prevented the NMDA-induced increase in cell proliferation. Moreover, we demonstrated that the phosphorylation levels of calcium/calmodulin-dependent protein kinase IV (CaMKIV) and cAMP response element binding protein (CREB) were increased by NMDA treatment, whereas Ro 25-6981 decreased them. The role that NR2B-containing NMDARs plays in NSPC proliferation was abolished when CREB phosphorylation was attenuated by CaMKIV silencing. These results suggest that NR2B-containing NMDARs have a positive role in regulating NSPC proliferation, which may be mediated through CaMKIV phosphorylation and subsequent induction of CREB activation. Crown
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762679     DOI: 10.1016/j.bbrc.2011.06.170

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Cyclin-dependent kinase 5 regulates proliferation, migration, tyrosinase activity, and melanin production in B16-F10 melanoma cells via the essential regulator p-CREB.

Authors:  Xiuqing Li; Ruifang Wang; Junzhen Zhang; Shanshan Yang; Kaiyuan Ji; Bin Du; Xuexian Liu; Bo Liu; Shuhui Qi; Qiong Jia; Ruiwen Fan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-05-08       Impact factor: 2.416

Review 2.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

3.  UCH-L1 inhibition involved in CREB dephosphorylation in hippocampal slices.

Authors:  Min Xie; Shao-Hui Wang; Zhi-Min Lu; Ying Pan; Qi-Cai Chen; Xiao-Mei Liao
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

4.  Differential Binding of Human ApoE Isoforms to Insulin Receptor is Associated with Aberrant Insulin Signaling in AD Brain Samples.

Authors:  Elizabeth S Chan; Christopher Chen; Tuck Wah Soong; Boon-Seng Wong
Journal:  Neuromolecular Med       Date:  2018-02-15       Impact factor: 3.843

5.  Autocrine glutamatergic transmission for the regulation of embryonal carcinoma stem cells.

Authors:  Lin Teng; Hui-Min Lei; Fan Sun; Shi-Min An; Ya-Bin Tang; Shuang Meng; Cong-Hui Wang; Ying Shen; Hong-Zhuan Chen; Liang Zhu
Journal:  Oncotarget       Date:  2016-08-02

6.  The Neurogenesis Actuator and NR2B/NMDA Receptor Antagonist Ro25-6981 Consistently Improves Spatial Memory Retraining Via Brain Region-Specific Gene Expression.

Authors:  Marina A Gruden; Alexander M Ratmirov; Zinaida I Storozheva; Olga A Solovieva; Vladimir V Sherstnev; Robert D E Sewell
Journal:  J Mol Neurosci       Date:  2018-05-22       Impact factor: 3.444

7.  NMDA receptors promote neurogenesis in the neonatal rat subventricular zone following hypoxic‑ischemic injury.

Authors:  Qingwei Lai; Peng Hu; Qingyun Li; Xinyu Li; Rui Yuan; Xiaohong Tang; Wei Wang; Xiaoquan Li; Hongbin Fan; Xiaoxing Yin
Journal:  Mol Med Rep       Date:  2015-11-04       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.